Love ❤️ RS

on arbitrage - almost no play there. I can buy a OTC or Naz stock in my CAD$ and my USD$ accts - they are deemed seperate so I deal with 4 CAD banks and each brokerage account has 2 sides and it looks like my TD ACCT actually has 4 sperate numbers as 2 are margin

yeah I saw that one also I bought 1 IGLDF
confirmed late but never hit the tape

I have 8 accounts - 4 accts with a CAD and USD side each I only did 1 this time

JUDO (daily list today) was one I've been trying for months to buy. One share.

bid was $1. No shares on ask.

1-500 reverse split. all shareholders rounded to 200 shares post RS.

Looks like bid dropped to $0.40 today. So 500 x .40 = $200/share post RS, and you'd get 200 shares lol.

again, no shares available. for months.

Regarding IGLDF, I read one of their past SEC filings for another reverse split (2019).

For that one, it looks like you needed to own more than .5 shares after RS to be rounded up, otherwise you'd be rounded down.

Treatment of Fractional Shares

In order to avoid the expense and inconvenience of issuing fractional shares (or payment therefor) in connection with the reverse share split, we intend to round any fractional share that results from the reverse share split to the nearest whole share (half-shares shall be rounded down).

https://igld.com/wp-content/uploads/2019/07/4.7-NOTICE-OF-2019-ANNUAL-AND-EXTRAORDINARY-GENERAL-MEETING-OF-SHAREHOLDERS-.pdf

Now Assuming the same criteria would apply for today's RS, you'd have to buy 126 shares at $5. And it's a big gamble to assume it would be the same.

IGLDF $5 doing a 250 for r/s no mentioned round up.

on round up note NDYN hit 2.97 today - was a 200 for 1 r/s then f/s . it worked out for me

SPRV REVERSE SPLIT 1:1000 12/16/20

TRON 1:200 Reverse Split.

https://ih.advfn.com/stock-market/USOTC/toron-pk-TRON/stock-news/83004620/toron-inc-announces-corporate-name-change-symbol

Never could buy that one restricted in Canada and people made a few hunderd per account. Played FW.V AHFCF yesterday round up

this is a new twist no play on it MGHL

TLGT Teligent to RS 1-10 on May 28

*Teligent: Intends to Effectuate a Reverse Stk Split in the Ratio of 10:1 in Order to Remove the Uncertainty That a Potential De-Listing Presents to Current and Future Investors >TLGT

*Teligent: Anticipate the Reverse Split Will Be Effectuated on May 28 >TLGT

If you love big R/S, this one's for you.

BRK Announces Reverse Split
PR Newswire
HENDERSON, Nevada, March 30, 2020
HENDERSON, Nevada, March 30, 2020 /PRNewswire/ -- BRK, Inc. (the "Company") (OTC: BRKK) the Company wishes to inform its shareholders that today, BRK Inc. filed a proposed reverse stock split in the State of Nevada. Important details are as follows:
The ratio for the reverse split is 1,000,000:1
No individual Shareholder will have less than 100 shares post reverse split. For example, an individual with 200,000 shares would have 100 shares post reverse split despite the ratio of 1,000,000:1 driving an adjusted r/s share amount of 0.2 shares.
The calculation for allocation of post reverse split shares is to be effectuated based on Shareholders of record as of March 30, 2020.

If it's true, that is.

gotta love those rev splits --specially the big ones

Delcath Sys DCTH says 1-700 for Dec. 24. Keeps A/S
Would be 3rd after 2 at 1-16 ratios. To be DCTHd 20 trade days.
Note A/S isn't being reduced leaving ample room for more you know what.

https://finance.yahoo.com/news/delcath-systems-announces-1-700-133010993.html?.tsrc=rss

NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-for-700 reverse stock split of the Company’s common stock. Stockholders authorized the Company’s Board of Directors to effect the reverse stock split at the annual meeting of stockholders on September 17, 2019. The reverse stock split will be effected prior to the initiation of trading on December 24, 2019. The reverse stock split supersedes the 1-for-100 reverse stock split previously announced on October 18, 2019 which was not effected.

Beginning with trading on December 24, 2019, shares of Delcath common stock will be designated by the symbol DCTHD for 20 trading days, and thereafter will revert to the symbol DCTH. The new CUSIP number for the common stock following the reverse stock split will be 24661P 807.

The reverse stock split will reduce the number of shares of common stock issued and outstanding or required to be reserved for issuance from approximately 1.4 billion to approximately 2.1 million but will not affect the authorized number of shares of common stock the Company is authorized to issue which will remain at 1 billion shares. Fractional shares resulting from the reverse stock split will be rounded up to whole shares.

American Stock Transfer & Trust Company, LLC is acting as the exchange agent and transfer agent for the reverse stock split. Stockholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse stock split. Beneficial holders are encouraged to contact their bank, broker or custodian with any procedural questions.

About Delcath System, Inc.

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product – Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) – is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. We have been enrolling a global Registration clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) called The FOCUS Trial and have initiated a global Phase 3 clinical trial for intrahepatic cholangiocarcinoma (ICC) called The ALIGN Trial. Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, our system is marketed under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT) and has been used at major medical centers to treat a wide range of cancers of the liver. Since January 2019 CHEMOSAT is marketed under an exclusive licensing agreement with medac, a privately held multi-national pharmaceutical company headquartered in Germany and specializing in the treatment and diagnosis of oncological, urological and autoimmune diseases.

another company screwing the pooch with bad info. Oddly enough my qiote provider shows me it r/s on Friday also.

GIGA hit daily list today for ex date tomorrow but company issued worng dates in NR. ITS still pre split. I do not see a play here that presplit shares are selling post split as it is still pre split

GIGA-TRONICS INC (U-GIGA) - News Release
Giga-tronics Incorporated Announces Completion of Previously Announced Reverse Split of Common Stock

2019-12-12 19:51 AT - News Release

DUBLIN, Calif., Dec. 12, 2019 (GLOBE NEWSWIRE) -- (OTCQB: GIGA) Giga-tronics Incorporated (the “Company”) announced today that its previously announced 1-for-15 reverse split of its common stock would become effective as of December 12, 2019. Beginning on December 13, 2019, the Company’s common stock will trade on the OTC market on a split-adjusted basis.

As a result of the reverse stock split, the number of shares of common stock outstanding will be reduced by the ratio of 1-for-15 to 2,476,982. The number of authorized shares of the Company’s common stock has been reduced in the same proportion to 13,333,333 shares of common stock. The reverse stock split impacts all holders of the Company’s common stock uniformly and will not impact any shareholder’s percentage ownership interest in the Company; however, no fractional shares will be issued in connection with the reverse stock split, and cash will be paid in lieu of any fractional shares. The reverse stock split also reduces the number of shares of common stock issuable upon the conversion of the Company’s outstanding shares of preferred stock and the exercise of its outstanding stock options and warrants in proportion to the ratio of the reverse stock split and causes a proportionate increase in the conversion and exercise prices of such preferred stock, stock options and warrants.

The Company’s common stock will continue to trade on the OTC under the symbol “GIGA”, although the letter “D” will be added to the end of the trading symbol for approximately 20 trading days after the effective time of the split to designate that it is trading on a post-split basis. The new CUSIP number for the common stock following the reverse stock split is 37517504.

Registered shareholders holding their shares of common stock in book-entry form or through a bank, broker or other nominee do not need to take any action in connection with the reverse stock split. For those shareholders holding physical stock certificates, the Company’s transfer agent, American Stock Transfer & Trust Company, LLC, will send instructions for exchanging those certificates for new certificates representing the post-split number of shares. The transfer agent’s phone number is AST can be reached at

VTNL did R/S on Oct 18 and still trades with the "D"? EOM

TWOH 1:1000 R/S

The following actions were authorized, by written consent, by the Majority Stockholder on the Record Date:
To effectuate a Reverse Stock Split of all the outstanding shares of the Company’s Common Stock at a ratio of one-for-1,000 (1:1,000), without changing the $0.0001 par value or authorized number of Common Stock, and rounding fractional shares resulting from the Reverse Stock Split up to the nearest whole number (the “Reverse Stock Split”).

CANB 1:300 Reverse Split
https://ih.advfn.com/stock-market/USOTC/canbiola-inc-CANB/stock-news/81159199/proxy-statement-other-information-preliminary-pr

DCTH Reverse Split postponed. EOM

DCTH 1:100 Reverse Split;

Time 10/21/2019 11:39:40
Event Type Reverse Split/CUSIP Change
Effective/Ex Date/Time 10/22/2019 00:00:00
Subject to Corporate Action CD
Offering Type No Restrictions
Daily List Comment
Daily List Event Code DA
Forward Split Ratio
Reverse Split Ratio 1:100
Dividend Type Reverse Split

PLX Protalix BioTherapeutics proxy for 1-10 to 1-20
Today 4:30PM ET

https://seekingalpha.com/filing/4664626

As part of our efforts to preserve our ongoing clinical development and to realize future benefits of commercial success, our Board of Directors, along with our Management team, have determined that it is in the company’s best interest to make certain changes to our capital structure. Accordingly, we have filed a proxy statement asking our stockholders to approve an amendment to our Certificate of Incorporation proposing the following two changes:
1)
A reverse stock split at a ratio of not less than 1-for-10 and not greater than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board of Directors before the day prior to the special meeting of stockholders without further approval or authorization of our stockholders.
2)
A reduction in the total number of shares of our common stock that we are authorized to issue from 350 million to 120 million shares.
If the proposal to amend our certificate of incorporation is approved, our Board of Directors will set the timing for the reverse stock split and select the specific ratio from within the preceding range of ratios.

SCON Superconductor Tech plans R/S 1-2 / 1-10. Proxy 14A

7am ET https://seekingalpha.com/filing/4663630

FLTT 1:50 Reverse Split;

07/22/2019 00:00:00
FLTT
FLTTD
Flint Telecom Group, Inc. Common Stock
Bull Run Capital Holdings, Inc. Common Stock

FCEL FuelCell Energy RS 1-12 at 5pm ET today
Unusual to post 12:45pm ET mid-day.

DANBURY, Conn., May 08, 2019 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today announced that a 1-for-12 reverse stock split will become effective at 5:00 p.m., Eastern time, today and that trading of the Company’s common stock on a post-split basis will begin on May 9, 2019.

Today, the Company filed a Certificate of Amendment of the Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware to effect a reverse stock split of its common stock at a ratio of 1-for-12. Trading of the Company’s common stock on the Nasdaq Global Market will continue under the symbol “FCEL.” The new CUSIP number for the Company’s common stock following the reverse stock split will be 35952H 601.

No fractional shares will be issued as a result of the reverse stock split. A holder of record of common stock on the effective date of the reverse stock split who would otherwise be entitled to a fraction of a share will instead be entitled to receive a cash payment for the fractional interest.

The Company’s transfer agent, American Stock Transfer & Trust Company, will act as exchange agent for the reverse stock split.

Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers’ particular processes, and will not be required to take any action in connection with the reverse stock split.

Registered stockholders holding pre-split shares of the Company’s common stock electronically in book-entry form are not required to take any action to receive post-split shares.

Stockholders of record holding certificates representing pre-split shares of the Company’s common stock as of the effective time will receive a letter of transmittal from American Stock Transfer & Trust Company providing instructions regarding (i) the exchange of shares and (ii) how to receive their cash payment in lieu of fractional shares, if applicable.
The reverse stock split will not change the total number of shares of common stock or preferred stock authorized for issuance by the Company. Additionally, the par value of the Company’s common stock will remain at $0.0001 per share.

The stockholders of the Company approved the reverse stock split at the 2019 Annual Meeting of Stockholders on April 4, 2019, and the Board of Directors of the Company subsequently approved the implementation of the reverse stock split at the ratio of 1-for-12.

Additional information regarding the reverse stock split is available in the definitive proxy statement filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on February 19, 2019. The definitive proxy statement is available at the Investors page of the Company website at www.fuelcellenergy.com and the SEC website.

About FuelCell Energy

FuelCell Energy, Inc. (FCEL) delivers state-of-the-art fuel cell power plants that provide environmentally responsible solutions for various applications such as utility-scale and on-site power generation, carbon capture, local hydrogen production for both transportation and industry, and long duration energy storage. Our systems cater to the needs of customers across several industries, including utility companies, municipalities, universities, government entities and a variety of industrial and commercial enterprises. With our megawatt-scale SureSource™ installations on three continents and with more than 8.0 million megawatt hours of ultra-clean power produced, FuelCell Energy is a global leader in designing, manufacturing, installing, operating and maintaining environmentally responsible fuel cell distributed power solutions. Visit us online at www.fuelcellenergy.com and follow us on Twitter @FuelCell_Energy.

SureSource, SureSource 1500, SureSource 3000, SureSource 4000, SureSource Recovery, SureSource Capture, SureSource Hydrogen, SureSource Storage, SureSource Service, SureSource Capital, FuelCell Energy, and FuelCell Energy logo are all trademarks of FuelCell Energy, Inc.

Contact:
FuelCell Energy
203.205.2491
ir@fce.com

Source: FuelCell Energy

EARS R/S 1-20 open. had 1-10 on 3/2018

Stock Split in General
Auris Medical Holding Ltd EARS:NASDAQ
Auris Medical Holding Ltd has announced a 1-20 split effective 5/1/19.

DAC (Danaos Corporation-NYSE) will do 1/14 reverse split effective 2 May 2019.

BioPharmX BPMX RS 1-25 for 4/26

AH drop .09 to .06 - .07 area

04:21 PM EDT, 04/15/2019 (MT Newswires) -- BioPharmX (BPMX) said on Monday its board has approved a reverse 1-for-25 stock split, effective on April 25, and the shares will begin trading on the split-adjusted basis on the NYSE on April 26 as part of its plan to regain compliance with NYSE American listing standards.
Price: 0.0899, Change: 0.00, Percent Change: +1.81

Rite Aid to reverse split shares 1:20 on 4/22
Apr. 10, 2019 4:32 PM ET| Rite Aid Corporation (RAD)|By: Douglas W. House, SA News Editor
The board of Rite Aid (NYSE:RAD) has authorized a 1:20 reverse split of its common stock. Post-split trading will commence on April 22.

Cardiff Lexington Corp (CDIX) Announces Reverse Stock Split
Email Print Friendly Share
March 25, 2019 10:41 ET | Source: Cardiff Lexington
FT. LAUDERDALE, Fla., March 25, 2019 (GLOBE NEWSWIRE) -- Cardiff Lexington Corporation (OTC:CDIX) announced today a (1:1,500) reverse stock split of its issued and outstanding common stock. The reverse stock split will be implemented when the market opens on Monday, March 25th, 2019 and Cardiff Lexington’s common stock will begin trading on a split-adjusted basis at that time, with a “D” temporarily appended to the end of its ticker symbol for 20 business days to signify the split. This Board of Directors action offsets the effects of toxic debt generated dilution which occurred over the past year as convertible note holders aggressively converted. This action is an important milestone in the Company’s ability to fix its capital structure and close future acquisitions.

The reverse stock split affects all issued and outstanding shares of Cardiff Lexington’s common stock, as well as shares of common stock underlying stock options, warrants and convertible preferred stock outstanding immediately prior to the reverse stock split. A majority of Cardiff’s stockholders approved and granted authority to the Board of Directors to effect the reverse stock split on February 22nd, 2019. The state of Florida approved the Company’s amended articles on March 5th, 2019 and final approval was received at the end of business on Friday, March 22nd, 2019. Under this reverse split, the number of shares outstanding on a fully diluted basis will be reduced to about 1.4 million shares. Reducing the number of new shares to be sold every month should reduce the selling pressure. This should allow the price to rise. Of course, there are no guarantees. Still, there is a tremendous amount of interest in Cardiff Lexington shares as is evidenced by the absorption of the large number of shares sold by the toxic lenders over the last year. Cardiff Lexington is now committed to reducing and avoiding toxic debt financing. The management of Cardiff Lexington thanks its loyal shareholders for their support. As always our goal is to increase long term shareholder value and we strongly feel we are on the right track.

“This action to reduce the number of issued and outstanding shares and correspondingly increase the company’s trading share price empowers the Company to continue to implement its core strategy of growth through acquisition,” stated Alex Cunningham, Cardiff Lexington’s CEO. “Last year the Company adopted a policy to no longer publicly announce entering into “Letters Of Intent” (LOI’s) to purchase another company; however, Cardiff Lexington is actively engaged in negotiations regarding several acquisitions which should offer higher returns for our investors and meet the required criteria for the Company’s planned uplisting to a major securities exchange. This reverse was critical to Cardiff Lexington’s core mission - continuous acquisitions to create broader diversification and increase overall revenue and profit.”

Cardiff Lexington continues to work with remaining holders of its convertible debt and equity securities to effectively eliminate the ability of those holders to convert their securities into common stock using a formula that relies on fluctuating market prices to determine the number of shares of common stock to be issued on conversion. Because these provisions can lead to dramatic stock price reductions and corresponding negative dilution effects on stockholders, these types of notes have colloquially been called “toxic” convertibles. Going forward, Cardiff Lexington is seeking agreement from remaining holders of notes with such provisions to modify those notes with terms which would effectively limit the reduction in earnings per share and proportional ownership that occurs when holders of convertible securities convert those securities into common stock.

Cardiff Lexington’s business model targets acquisition of middle market private niche companies both mature and second stage with high growth potential. While debt conversions greatly reduced Company debt, the negative impact to the Cardiff Lexington share price has made closing transactions difficult. Restructuring was necessary to continue acquisitions.

The Cardiff Lexington umbrella enables business owners to exit personal equity and to take advantage of the capitalization power of a public company without losing independent management control. Fundamental to the Cardiff Lexington strategy, acquisitions become standalone autonomous subsidiaries gaining advantage of the power of a public company. Owners gain liquidity, diversification, pooled resources, leverage value, and mitigated risk. As a Cardiff Lexington subsidiary, these companies gain both the enhanced ability to raise money for operations or expansion while also establishing a longer-term equity exit strategy.

For Investors, Cardiff Lexington seeks to aggressively grow and hold assets that create a diversified lower risk environment that over the long term protects and safely enhances investment through a diversified continually growing niche holding company.

INFORMATION FOR STOCKHOLDERS

Cardiff Lexington new transfer agent, Transfer Online (https://www.transferonline.com/), which is also acting as the exchange agent for the reverse split, will provide instructions to stockholders regarding the process for exchanging share certificates. Any fractional shares of common stock resulting from the reverse stock split will be rounded up to the nearest whole post-split share and no stockholders will receive cash in lieu of fractional shares.

About Cardiff Lexington Corporation: Cardiff Lexington is a public holding company, much like a cooperative, leveraging proven management in private companies that become subsidiaries. Our focus is not industry or geographic-specific, but rather proven management, market, and margin. Cardiff Lexington targets acquisitions of mature, high growth, niche companies. Cardiff Lexington's strategy identifies and empowers select income-producing middle market private businesses and commercial real estate properties. Cardiff Lexington provides these companies both 1) the enhanced ability to raise money for operations or expansion, and 2) an equity exit and liquidity strategy for the owner, heirs, and/or Investors. For investors, Cardiff Lexington provides a diversified lower risk to protect and safely enhance their investment by continually adding assets and holdings. Cardiff Lexington is led by a strong and talented team of executives and advisors providing expert acquisition, market guidance and added value for subsidiaries and investors.

FORWARD LOOKING STATEMENT: This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.

Investor Relations
800-628-2100 ext. 705
investorrelations@cardifflexington.com

Source: Cardiff Lexington Corporation

ELGX Endologix selects R/S 1-10 at Open today

https://www.streetinsider.com/Press+Releases/Endologix+Announces+Approval+of+Reverse+Stock+Split/15219992.html

IRVINE, Calif.--(BUSINESS WIRE)-- Endologix, Inc. (the “Company”) (NASDAQ: ELGX) previously announced that a proposal was approved at its Special Meeting of Stockholders, held February 22, 2019, authorizing its Board of Directors to amend the Company's certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio not less than 1-for-5 and not greater than 1-for-10 (inclusive), with the exact ratio to be set within that range by the Company’s Board of Directors. The number of authorized shares of common stock would remain at 170 million shares, and the number of authorized shares of preferred stock would remain at 5 million shares.?The Company’s Board of Directors had previously directed that the proposal be submitted to the stockholders for approval and has subsequently approved the reverse stock split at a ratio of 1-for-10. The reverse stock split will take effect at 4:00 p.m. ET on March 5, 2019. Beginning with the opening of trading on March 6, 2019, the Company's common stock will trade on the NASDAQ Global Select Market on a reverse stock split-adjusted basis.

Upon the effectiveness of the reverse stock split, every ten shares of the Company's issued and outstanding common stock will be automatically reclassified and converted into one issued and outstanding share of common stock, par value $0.001 per share. As a result of the reverse split, there will be approximately 10.3 million shares of common stock issued and outstanding. The shares of common stock will trade under a new CUSIP number, 29266S304, effective March 6, 2019.?The Company’s trading symbol will remain “ELGX.” All options, warrants, and convertible securities of the Company outstanding immediately prior to the reverse stock split will be adjusted.

No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders who would otherwise be entitled to receive a fractional share as a result of the reverse stock split will instead receive one whole share of common stock.

The Company has chosen its transfer agent, American Stock Transfer & Trust Company, LLC (“AST”), to act as exchange agent for the reverse stock split.?Stockholders owning shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, and will not be required to take further action in connection with the reverse stock split, subject to brokers' particular processes.?For those stockholders holding physical stock certificates, AST will send instructions for exchanging those certificates for shares held in book-entry form representing the post-split number of shares. AST can be reached at (800) 937-5449.

HMNY wants 1-2 / 1-500 RS vote 3/15

MoviePass parent Helios & Matheson seeks another reverse-stock split of up to 1-for-500 shares
Today 12:54 PM ET (MarketWatch)
Share
Print
Helios & Matheson Analytics Inc. (HMNY), the parent of the film loyalty program MoviePass, has set March 15 as the date for a meeting on its latest plan for a reverse-stock split that would help avert a delisting. In a regulatory filing, the company invited shareholders to a meeting at 10.00 a.m. Pacific Time on that date to vote on a reverse split of its stock at a ratio of 1-for-2 shares up to 1-for-500 shares, . The stock has closed below the $1 threshold for an exchange listing since July. It has closed beneath a nickel every day since August and was last quoted at 1 cent. The data company has struggled to make MoviePass profitable and has been burning through cash. It first bought a majority stake in the program in 2017 and immediately cut the price to $9.95 a month allowing subscribers see a film of their choice every day. When that proved untenable, it changed the terms of its offering, limiting access to bigger films and restricting customers to certain showings. It has already implemented a 1-for-250 reverse stock split and has sold preferred stock and convertible notes to raise fresh funds. New York Attorney General Barbara Underwood has launched a securities fraud investigation into the company.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

Rite Aid to reverse split shares 1-10-15-20 3.21.19
Jan. 25, 2019 4:30 PM ET|About: Rite Aid Corporation (RAD)|By: Douglas W. House, SA News Editor
Aimed at regaining compliance with NYSE's listing standard of a $1 minimum bid price, Rite Aid (NYSE:RAD) will reverse split its common stock either 1:10, 1:15 or 1:20 subsequent to a vote from shareholders on March 21.

A preliminary proxy statement will be filed later today.

+++++++++++ Proxy details below Given size of the 1B+ OS likely 1-20

https://ih.advfn.com/stock-market/NYSE/rite-aid-RAD/stock-news/79123695/proxy-statement-notice-of-shareholders-meeting-p

BICX 1:100

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146286807

75% haircut today on WDBG -
STSC splitting 2000 for 1 for tomorrow

WDBG 1:9,000

https://backend.otcmarkets.com/otcapi/company/financial-report/209871/content

the RYSMF r/s was quite a screwup and still not clear on when it happened

CREIY r/s ex date tomorrow the 13th bid ask looking like today - possible short opp but that could get messy and since it never traded before you will be hard pressed to find borrows and get a short executed.

I didn't play it

Not me sadly

It is more geared towards those who end up with a bunch us a fractional rich folk lol it's a no.play

PACDQ, that one confused me. it doesn't say you'd receive $19.62 per pre-split share, it states:

holders of fractional shares will be paid out in cash for any fractional interests based on the implied plan value (or $19.62 per share), which is not expected to be material in the aggregate.

So I'm guessing its $19.62 multiplied by whatever fractional share you have after the reverse split.

That would suck!

if you bought 9999 shares at $0.10, (costing $999.9) you'd have .9999 shares after the reverse split, and receive

.9999 x $19.62 = $19.62 for the "fractional interest"

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144945502

More trades after hours. Nice profits for "whoever"

i was reversed out of my one share in 2 accounts of SINC as expected but 8 trades today for 1 or two shares so someone got their onesies
correction I have one SINCD but bid is $50
PACDF is reversing 10,000 for one and fractionals cashed out at $19 per share so if you have free commissions then $19 up for grabs lol seems like a lot of work

I misspoke. I thought they backdated it - They moved the ex date up one day to tomorrow

Yes it was as it was MXSV MVES. I bought them and received my round up and sold in 4 accounts for bug gains and a month later my broker reversed all of the trades - best as I can recall.

ah yes, I remember that name. I still have shares of SHCC (the old Matrix Energy Services Corp). from back in 2008. I think that was the backdated one.

lol -->> https://investorshub.advfn.com/boards/read_msg.aspx?message_id=28508560

OK - I see now - they have backdated the ex date. The stock barely traded so I am sure it impacts very few but a 1000 for 1 reverse split and the pps never changed.


HUMM last guy who did this was Nathan Drage who was the laywer for some stinky - Pretty sure he ended up in jail on something unrelated.

I am sure they will NOT honor the round up

I see now the original SINC daily-list posting didn't mention fractional share round up either, (as per Buckey's first mention) so hmm. Don't know why they'd cancel the effective date, and repost it on Monday, unless it was a Finra goof, posting it a day too early.

I thought it might have been SINC pulling the posting because they are changing the fractional-share condition.

it'll probably have no bid after reverse split anyway lol.

One would think, that if a company puts out information in an SEC filing, causing people to buy the stock, and they don't adhere to what is stated in the filing,

..that there would be consequences, but I've been burned so many times with this kinda stuff.

What we need is MORE chinese companies incorporated in Nevada please!!!